See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0000810509_2018_Navidea_Biopharmaceuticals_Inc.pdf
Logs
info |
Added remainder_ComprehensiveNetIncome directly from 10K |
industry.us_generic |
{} |
Graph
Absolute values for 0000810509, Navidea Biopharmaceuticals Inc.
|
xvar |
xval |
0 |
LiabilitiesNoncurrent |
76,611 |
1 |
LiabilitiesCurrent |
8,068,403 |
2 |
remainder_Liabilities |
588,092 |
3 |
AssetsCurrent |
13,832,405 |
4 |
AssetsNoncurrent |
1,444,798 |
5 |
PropertyPlantAndEquipmentNet |
236,701 |
6 |
Goodwill |
458,156 |
7 |
remainder_Assets |
4,809,376 |
8 |
GeneralAndAdministrativeExpense |
11,169,951 |
9 |
ResearchAndDevelopmentExpense |
4,513,842 |
10 |
remainder_Expenses |
-4,058,838 |
11 |
remainder_Revenues |
1,810,437 |
12 |
remainder_NetIncome |
84,760,374 |
13 |
remainder_ComprehensiveNetIncome |
-2,396 |
|
yvar |
yval |
0 |
Liabilities |
8,733,106 |
1 |
Assets |
20,781,436 |
2 |
Expenses |
11,624,955 |
3 |
Revenues |
1,810,437 |
4 |
StockholdersEquity |
12,048,330 |
5 |
NetIncome |
74,945,856 |
6 |
ComprehensiveNetIncome |
74,944,658 |
7 |
BaseVar |
63,856,352 |
8 |
EconomicCapitalRatio |
5.77 |
Edgar->Model Mapping
Feature Distribution
Change over Time